Bioleap
PrivateCompany Overview
Bioleap is a biotechnology company that develops an AI-powered, physics-first biosimulation platform to accelerate drug discovery and the development of complex biologics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
biosimulationin-silico drug discoverymechanistic modelingquantitative systems pharmacologyQSPhybrid-AIpatient stratificationimmuno-oncologybiologics developmentdigital twincomputational biologyclinical trial optimizationAI drug discoverypharma R&D softwarebiotech consulting
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioleap Comparables
Compare Bioleap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Netabolics | 87% | |
| VeriSIM Life | 82% | |
| InSysBio | 79% | |
Bioleap Funding Rounds
Historical fundraising activity
Bioleap Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioleap's valuation, stock price, and market status.